Indication
For treatment of adults with primary immunoglobulin A nephropathy (IgAN) with a urine protein excretion ≥1.0 g/day (or urine protein-to-creatinine ratio ≥0.8 g/g).
Medicine details
- Medicine name:
- budesonide modified release (Kinpeygo)
- SMC ID:
- SMC2814
- Pharmaceutical company
- Genus Pharmaceuticals
- BNF chapter
- Nutrition and blood
- Submission type
- Full
- Publication due date:
- TBC
- SMC meeting date:
- TBC
- Patient group submission deadline:
- TBC